Sanofi-Aventis 4Q10 4Q Revenues: $10.0 billion (8%) 4Q Earnings: $594 million (-67%) FY Revenues: $40.3 billion (-1%) FY Earnings: $7.3 billion (-1%) Comments: Figures are skewed by the 8% drop in EUR to USD exchange rate from 4Q09 to 4Q10 and the 5% drop from FY09 to FY10. At constant exchange rates, 4Q10 revenues were down 6% and FY10 revenues were up 1%. Lantus sales were up 9% for 4Q and FY to $1.2 billion and $4.6 billion, respectively. Lovenox sales were hurt by U.S. generic...